SUNZEN BIOTECH BHDSUNZEN BIOTECH BHDSUNZEN BIOTECH BHD

SUNZEN BIOTECH BHD

No trades
See on Supercharts
Market capitalization
‪232.36 M‬MYR
‪6.80 M‬MYR
‪98.13 M‬MYR
Beta (1Y)
−0.14

About SUNZEN BIOTECH BHD

CEO
Yek Ming Teo
Headquarters
Shah Alam
Founded
2005
ISIN
MYQ0148OO005
FIGI
BBG000DZ8FV1
Sunzen Biotech Bhd. is an investment holding company, which engages in the business of biotechnology research and development, manufacturing, and marketing of animal feed supplement products. It operates through the following segments: Manufacturing and Trading of Animal Health Products; Traditional Chinese Medicines and Herbal Health Foods and Beverages; and Loan Financing. The company was founded by Kim Sing Tan, Kim Lai Teo, and Poe Chu Kok on February 8, 2005 and is headquartered in Shah Alam, Malaysia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SUNZEN is 0.310 MYR — it has decreased by 4.62% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on MYX exchange SUNZEN BIOTECH BHD stocks are traded under the ticker SUNZEN.
SUNZEN stock is 10.17% volatile and has beta coefficient of −0.14. Check out the list of the most volatile stocks — is SUNZEN BIOTECH BHD there?
Yes, you can track SUNZEN BIOTECH BHD financials in yearly and quarterly reports right on TradingView.
SUNZEN stock has fallen by 8.82% compared to the previous week, the month change is a 3.13% fall, over the last year SUNZEN BIOTECH BHD has showed a 44.19% increase.
SUNZEN net income for the last quarter is ‪3.11 M‬ MYR, while the quarter before that showed ‪1.69 M‬ MYR of net income which accounts for 83.70% change. Track more SUNZEN BIOTECH BHD financial stats to get the full picture.
Today SUNZEN BIOTECH BHD has the market capitalization of ‪229.22 M‬, it has increased by 1.49% over the last week.
SUNZEN BIOTECH BHD dividend yield was 0% in 2023, and payout ratio reached 0%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, SUNZEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUNZEN BIOTECH BHD stock right from TradingView charts — choose your broker and connect to your account.
SUNZEN reached its all-time high on Jun 24, 2015 with the price of 0.465 MYR, and its all-time low was 0.015 MYR and was reached on Apr 8, 2010.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUNZEN BIOTECH BHD technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUNZEN BIOTECH BHD stock shows the buy signal. See more of SUNZEN BIOTECH BHD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUNZEN BIOTECH BHD EBITDA is ‪14.51 M‬ MYR, and current EBITDA margin is 14.89%. See more stats in SUNZEN BIOTECH BHD financial statements.